https://www.selleckchem.com/pr....oducts/larotrectinib
Background Luteal-phase ovarian stimulation (LPOS) is an alternative in vitro fertilization (IVF) protocol. However, limited data showed the genes expression of cumulus cells (CCs) in LPOS. Therefore, this study aimed to investigate CC genes expression between LPOS and follicular-phase ovarian stimulation (FPOS) in poor ovarian responders (PORs) undergoing IVF cycles. Methods This was a prospective non-randomized trial (ClinicalTrials.gov Identifier NCT03238833). A total of 36 PORs who met the Bologna criteria and underwent IVF cy